Search

everythinglearnresearchcommunity

for

Search:↓

About 41% of Indian hair loss patients have low enzyme activity that affects hair loss treatment effectiveness, with men affected more than women. Testing for this can guide treatment.

Male pattern hair loss is diagnosed and treated earlier and is milder, possibly due to early puberty.

A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.

Researchers found a new mutation causing total hair loss from birth.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

NF-κB levels can help diagnose and assess the severity of androgenetic alopecia.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

New method measures skin cell turnover quickly and effectively, showing turnover slows with age and responds more to treatments in older skin.

Menthol boosts the hair growth effects of Phyllanthus niruri gel.

Iontophoresis with a growth factor cocktail helps hair growth in patients with androgenetic alopecia.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Human adrenals and gonads have a unique enzyme for steroid hormone production.

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.

Blocking 11β-HSD1 reduces stress hormone damage in hair growth cells.

3βHSD2 is not useful for diagnosing PCOS.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

A genetic defect causes males in some Mediterranean populations to be born with ambiguous genitalia and develop male traits at puberty.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Certain enzymes react strongly with some hormones in rat skin during hair growth, mainly in sebaceous glands and hair sheaths.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.